More PTAB Fights Between Big Pharma Could Be Looming
Pharmaceutical firms like Pfizer Inc. are accustomed to having their patents for brand-name drugs challenged by generics makers at the Patent Trial and Appeal Board. But companies that make innovative new...To view the full article, register now.
Already a subscriber? Click here to view full article